NDC Package 70882-105-56 Pioglitazone And Metformin

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

70882-105-56

Package Description:

56 TABLET, FILM COATED in 1 BLISTER PACK

Product Code:

70882-105

Proprietary Name:

Pioglitazone And Metformin

Usage Information:

Pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate [see CLINICAL STUDIES (14)].Important Limitations of UsePioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone and metformin hydrochloride tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings.Use caution in patients with liver disease [see WARNINGS AND PRECAUTIONS (5.5)].

11-Digit NDC Billing Format:

70882010556

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

56 EA

NDC to RxNorm Crosswalk:

RxCUI: 861783 - pioglitazone 15 MG / metFORMIN HCl 500 MG Oral Tablet

RxCUI: 861783 - metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet

Labeler Name:

Cambridge Therapeutics Technologies, Llc

Sample Package:

Start Marketing Date:

05-02-2013

Listing Expiration Date:

12-31-2018

Exclude Flag:

Code Structure:

70882 - Cambridge Therapeutics Technologies, Llc
- 70882-105 - Pioglitazone And Metformin
  - 70882-105-56 - 56 TABLET, FILM COATED in 1 BLISTER PACK

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70882-105-56?

The NDC Packaged Code 70882-105-56 is assigned to a package of 56 tablet, film coated in 1 blister pack of Pioglitazone And Metformin, labeled by Cambridge Therapeutics Technologies, Llc. The product's dosage form is and is administered via form.

Is NDC 70882-105 included in the NDC Directory?

No, Pioglitazone And Metformin with product code 70882-105 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Cambridge Therapeutics Technologies, Llc on May 02, 2013 and its listing in the NDC Directory is set to expire on December 31, 2018 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 70882-105-56?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 56.

What is the 11-digit format for NDC 70882-105-56?

The 11-digit format is 70882010556. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	70882-105-56	5-4-2	70882-0105-56

Table of Contents